TPK1 and nosocomial infection: Furthermore, our finding that mutation of CYR1, TPK1, TPK2, or BCY1 significantly promoted the disinfectant susceptibility of C. auris suggests that addition of inhibitors or activators of the cAMP/PKA pathway to commercially available disinfectant could further prevent nosocomial infection of C. auris in a health care environment.